Physician profile
Robert C Green
NPI 1134182769
$14,062.20
in general payments reported to CMS, 2019-2025
9 companies · $5,428 in 2025
The $5,428 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,424 · 2022: $1,877 · 2023: $5,296 · 2024: $36.95 · 2025: $5,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $36.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,724.00 |
| Food and Beverage | $36.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illumina, INC. | $5,372.85 | 2022-2023 | Reproductive Health |
| Genzyme Corporation | $3,428.00 | 2025 | |
| Biomarin Pharmaceutical INC. | $2,000.00 | 2025 | |
| Pfizer INC. | $1,800.00 | 2022 | |
| Biogen, INC. | $1,314.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.45 | 2019 | |
| Janssen Global Services, LLC | $36.95 | 2024 | |
| Optinose US, INC. | $17.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.